- Citations, last 5 years
- 183.8k
- Works, last 5 years
- 38.6k
- h-index
- 821
- Scientists listed
- 3 447
- Grants since 2016
- 3 103
Grants received
2025–2030 · research · R25
Kentucky Postbaccalaureate Alzheimer’s Disease Research Education Program (KYPAD)
Luke H Bradley · University of Kentucky · funded by National Institutes of Health
2025–2028 · cooperative agreement · U2F
University of Kentucky Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
Glen Alan Harrison · University of Kentucky · funded by U.S. Food and Drug Administration
2025–2026 · research · R13
Don S. Fredrickson Lipid Research Conference
Gregory A Graf · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
Harnessing the inflammatory response to promote regeneration in mammals
Jennifer Simkin · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
RNA modifications leading to pathophysiological translation of circRNAs in AD
Stefan Stamm · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R35
Molecular Biophysics of Dynamic Bacterial Nanomachines
Carrie Shaffer · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
The MiLC Study: Moringa in Lactation and Early Childhood
Philip A Kern · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
Role of Hypothalamic Adgrl1 in Counteracting Hypoglycemia
Kavaljit H Chhabra · University of Kentucky · funded by National Institutes of Health
2025–2027 · research · R21
Investigation of the role(s) chlamydial polymorphic membrane proteins (Pmps) play during infection with C. trachomatis
Katerina Wolf · University of Kentucky · funded by National Institutes of Health
2025–2027 · research · R21
Protective roles of CD180 and NOD1 in the protective immunity against cerebral Toxoplasma infection
Yasuhiro Suzuki · University of Kentucky · funded by National Institutes of Health
2025–2028 · fellowship · F30
Fellowship for Annabel McAtee: Elucidating the role of the dura mater in the post-stroke B cell response
Annabel Mcatee · University of Kentucky · funded by National Institutes of Health
2025–2027 · research · R21
Pathways to Prevention: Exploring Social Determinants of Health in Early Onset Colorectal Cancer
Justin Xavier Moore · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
Engineering Mechanisms Causing Adverse Biofilm Responses to 3D Printed Titanium Surfaces
Martha Grady · University of Kentucky · funded by National Institutes of Health
2025–2029 · career development · K01
Effects of Repeated CBD Administration on Cannabis Abuse-Liability and Analgesia: A Human Laboratory Study
Hannah Marie Harris · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
Advancing Non-Abstinence Outcomes in the Treatment of Methamphetamine Use Disorder
William Walton Stoops · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
Blood-Brain Barrier Dysfunction in Alzheimer’s Disease: New Mechanistic Insights and Therapeutic Strategies
Anika M.S. Hartz · University of Kentucky · funded by National Institutes of Health
2025–2027 · fellowship · F31
Next-Day Effects of Binge Drinking on Inhibitory Control in Laboratory and Naturalistic Settings
Justin James Verlinden · University of Kentucky · funded by National Institutes of Health
2025–2027 · research · R21
Adjuvanted Intranasal influenza vaccine to generate lung resident-memory T cells
Siva Kumar Gandhapudi · University of Kentucky · funded by National Institutes of Health
2025–2029 · research · R35
Gene regulatory network plasticity in social behavior
Beryl M Jones · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R35
Targeting Membrane Environments: The Role of Oleate Hydratase (OhyA) in Lipid-Protein Interactions Across Microbial Communities
Christopher David Radka · University of Kentucky · funded by National Institutes of Health
2025–2030 · research · R01
Using the gut microbiome to treat skeletal muscle atrophy
John Joseph Mccarthy · University of Kentucky · funded by National Institutes of Health
2025–2027 · research · R61
Liposomal azithromycin to treat cardiac inflammation
Ahmed Abdel Latif · University of Kentucky · funded by National Institutes of Health
2025–2028 · research · R00
Sex and physiological State dependent molecular characterization of circuits governing parental behavior
Brandon Logeman · University of Kentucky · funded by National Institutes of Health
2025–2029 · research · R01
Advancing Troriluzole as a Treatment for Methamphetamine Use Disorder: A Human Laboratory Study
William Walton Stoops · University of Kentucky · funded by National Institutes of Health
2025–2026 · grant · OT2
The East Palestine Train Derailment Health Research Program
Erin N Haynes · University of Kentucky · funded by National Institutes of Health
2025–2028 · research · R01
Targeting Immune Inflammation in Cocaine Use Disorder: A Human Laboratory Study with Pentoxifylline
William Walton Stoops · University of Kentucky · funded by National Institutes of Health
2025–2030 · program · P20
Muscle-derived extracellular vesicles and their interactions with adipocytes in human metabolic dysfunction
Yuan Wen · University of Kentucky · funded by National Institutes of Health
2025–2030 · program · P20
Diabetes Prevention Data Solutions Core
Xiaohua Douglas Zhang · University of Kentucky · funded by National Institutes of Health
2025–2030 · program · P20
Fructose breakdown uniquely controls global metabolism
Samir Softic · University of Kentucky · funded by National Institutes of Health
2025–2030 · program · P20
Diabetes Prevention Phenotyping Core
Philip A Kern · University of Kentucky · funded by National Institutes of Health
2025–2030 · program · P20
University of Kentucky Diabetes Prevention COBRE (UK-DPC)
Simon J Fisher · University of Kentucky · funded by National Institutes of Health
2025–2030 · program · P20
Monoclonal antibodies as a therapeutic to prevent Type 2 Diabetes
Ila Mishra · University of Kentucky · funded by National Institutes of Health
2024–2025 · research · R61
An innovative, trauma-informed approach for reducing overdose risk among women re-entering the community from prison
Kevin Knight · University of Kentucky · funded by National Institutes of Health
2024–2026 · fellowship · F31
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
Zachary A Kipp · University of Kentucky · funded by National Institutes of Health
2024–2028 · research · R37
Mechanistic and structural insights into a new pro-metastatic collagen glucosyltransferase
Houfu Guo · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R01
Fatty Acid Synthase as a Novel Molecular Target for Colon Cancer Treatment
Bernard Mark Evers · University of Kentucky · funded by National Institutes of Health
2024–2027 · fellowship · F31
Using the gut microbiome to treat disuse atrophy in aging.
Benjamin Burke · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R00
The Role of SoxE Transcription Factors in Neural Crest Cell Specialization
Elizabeth Schock · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R01
Characterization and Modulation of Functional Connectivity and Fear Extinction Abnormalities in Obsessive-Compulsive Disorder
Thomas G Adams · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R18
Disseminating and Implementing MedSMA℞T Families in Emergency Departments: A Randomized Control Trial to Assess Effectiveness of an Evidence-Based Gaming Intervention to Reduce Opioid Misuse
Olufunmilola Abraham · University of Kentucky · funded by Agency for Healthcare Research and Quality